In Reply: Neoadjuvant TKI Study in Early- and Intermediate Stage Hepatocellular Carcinoma
Journal article published in 2022 by
Susanne Osanto,
F. J. Sherida H. Woei-A.-Jin,
Nir I. Weijl,
Minneke J. Coenraad,
Mark C. Burgmans,
Jacobus Burggraaf,
F. J. Sherida H. Woei A. Jin 
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
This letter to the editor responds to comments from Rizzo et al on recently reported results of a phase II study of dovitinib therapy for hepatocellular carcinoma.